Key result
The 1.9-A crystal structure of CTX A3 in complex with SDS reveals how lipid-induced cardiotoxin dimerization transforms into oligomers for membrane fusion and pore formation.
The study elucidates the structural basis of lipid-induced cardiotoxin dimerization and oligomerization, highlighting a potential role for SDS in x-ray diffraction studies of protein-membrane interactions.
Does not inform clinical cardiotoxin management; leaves open translation of oligomerization mechanisms to human membrane injury.
Cobra cardiotoxins (CTXs) have previously been shown to induce membrane fusion of vesicles formed by phospholipids such as cardiolipin or sphingomyelin. CTX can also form a pore in membrane bilayers containing a anionic lipid such as phosphatidylserine or phosphatidylglycerol. Herein, we show that the interaction of CTX with negatively charged lipids causes CTX dimerization, an important intermediate for the eventual oligomerization of CTX during the CTX-induced fusion and pore formation process. The structural basis of the lipid-induced oligomerization of CTX A3, a major CTX from Naja atra, is then illustrated by the crystal structure of CTX A3 in complex with SDS; SDS likely mimics anionic lipids of the membrane under micelle conditions at 1.9-A resolution. The crystal packing reveals distinct SDS-free and SDS-rich regions; in the latter two types of interconnecting CTX A3 dimers, D1 and D2, and several SDS molecules can be identified to stabilize D1 and D2 by simultaneously interacting with residues at each dimer interface. When the three CTXSDS complexes in the asymmetric unit are overlaid, the orientation of CTX A3 monomers relative to the SDS molecules in the crystal is strikingly similar to that of the toxin with respect to model membranes as determined by NMR and Fourier transform infrared methods. These results not only illustrate how lipid-induced CTX dimer formation may be transformed into oligomers either as inverted micelles of fusion intermediates or as membrane pore of anionic lipid bilayers but also underscore a potential role for SDS in x-ray diffraction study of protein-membrane interactions in the future.
No takes yet. Share an insight, caveat, or question.
Forouhar et al. (2003) studied this question. Cobra cardiotoxin A3 (CTX A3) in complex with SDS was evaluated on Crystal structure resolution and oligomerization state. The 1.9-A crystal structure of CTX A3 in complex with SDS reveals how lipid-induced cardiotoxin dimerization transforms into oligomers for membrane fusion and pore formation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: